Celularity CELU
NASDAQ CELU
$1.05 +0.03 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Celularity (CELU) Price to Earnings (2019 - 2023)

Updated

Celularity's (CELU) Price to Earnings was 7.85 for Q1 2023, down 42.0% from the prior quarter.

Analysis

Celularity (CELU) Price to Earnings (2019 - 2023) Analysis & Trends

For FY2022, Price to Earnings at Celularity was 13.54.

  • By year, Price to Earnings came in at 142.29 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Celularity 28.63 Mn 21.39 Mn 3.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 7.85
Dec 31, 2022 13.54
Jun 30, 2022 15.69
Mar 31, 2020 9.59
Dec 31, 2019 31.74
API Access

Celularity Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=CELU&period=max&api_key=YOUR_API_KEY